Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Vaccine Adjuvants Industry?

There has been substantial growth in the vaccine adjuvants market size in the past few years. The market, which is anticipated to increase from $1.89 billion in 2024 to $2.01 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.6%. Factors such as enhanced vaccine development, rise in infectious diseases, government-driven initiatives and immunization programs, investments in research and development, and the global spread of vaccine distribution have largely contributed to this historical growth.

The market size for vaccine adjuvants is projected to experience significant growth in the upcoming years, increasing to $2.83 billion by 2029 with a compound annual growth rate (CAGR) of 8.9%. This predicted growth during the forecast period is due to factors such as preparedness for pandemics, an increasing range of vaccines, worldwide immunization objectives, partnerships and collaborations, and a focus on therapeutic vaccines. Key trends for the forecast period comprise advancements in adjuvant technologies, efforts to improve immunogenicity, the use of combination adjuvants for greater efficacy, demand for safer and more tolerated adjuvants, and personalized vaccines and adjuvants.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp

#Which Factors Are Currently Driving The Growth Of The Vaccine Adjuvants Market?

The growth of the vaccine adjuvants market is anticipated to be driven by the increasing occurrence of infectious diseases. These infectious diseases, caused by viruses, bacteria, fungi, or parasites, include conditions like hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis, which are treated using vaccines. The 2022 report from the World Health Organization (WHO) highlighted that an estimated 10.6 million people worldwide were affected by tuberculosis in 2021, with 1.6 million deaths, and another 1.5 million contracting HIV in the same year, leading to 650,000 fatalities. As such, the escalating rates of infectious diseases are expected to boost the vaccine adjuvants market.

How Is The Global Vaccine Adjuvants Market Structured In Terms Of Segments?

The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types

2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal

4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:

1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions

2) By Pathogen Components: Bacterial Components, Viral Components

3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles

4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems

5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

What Trends Are Currently Influencing Growth In The Vaccine Adjuvants Market?

Product innovation is an emerging trend that is becoming prominent in the travel vaccine market. In order to maintain their market stance, leading companies involved in the travel vaccine market are creating novel vaccines. For instance, Takeda Pharmaceutical Company Limited, a pharmaceutical firm based in Japan, received approval for QDENGA (Dengue Tetravalent Vaccine) (TAK-003) in August 2022. This approval was granted by the Indonesia National Agency for Drug and Food Control for the prevention of dengue disease caused by any serotype in individuals aged between six to 45. Independent of an individual’s previous exposure to the disease, QDENGA has proven to offer overall protection against dengue disease and hospitalization three years post-immunization.

Who Are The Main Participants Shaping The Vaccine Adjuvants Market Landscape?

Major companies operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Which Region Currently Holds The Largest Share In The Vaccine Adjuvants Market?

North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10121&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model